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Abstract
Background: People with Parkinson's disease are twice as likely to be recurrent fallers compared
to other older people. As these falls have devastating consequences, there is an urgent need to
identify and test innovative interventions with the potential to reduce falls in people with
Parkinson's disease. The main objective of this randomised controlled trial is to determine whether
fall rates can be reduced in people with Parkinson's disease using exercise targeting three
potentially remediable risk factors for falls (reduced balance, reduced leg muscle strength and
freezing of gait). In addition we will establish the cost effectiveness of the exercise program from
the health provider's perspective.
Methods/Design: 230 community-dwelling participants with idiopathic Parkinson's disease will be
recruited. Eligible participants will also have a history of falls or be identified as being at risk of falls
on assessment. Participants will be randomly allocated to a usual-care control group or an
intervention group which will undertake weight-bearing balance and strengthening exercises and
use cueing strategies to address freezing of gait. The intervention group will choose between the
home-based or support group-based mode of the program. Participants in both groups will receive
standardized falls prevention advice. The primary outcome measure will be fall rates. Participants
will record falls and medical interventions in a diary for the duration of the 6-month intervention
period. Secondary measures include the Parkinson's Disease Falls Risk Score, maximal leg muscle
strength, standing balance, the Short Physical Performance Battery, freezing of gait, health and well
being, habitual physical activity and positive and negative affect schedule.
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Discussion: No adequately powered studies have investigated exercise interventions aimed at
reducing falls in people with Parkinson's disease. This trial will determine the effectiveness of the
exercise intervention in reducing falls and its cost effectiveness. This pragmatic program, if found
to be effective, has the potential to be implemented within existing community services.
Trial registration: The protocol for this study is registered with the Australian New Zealand
Clinical Trials Registry (ACTRN12608000303347).
Background
The number of persons with Parkinson's disease over age
50 in Western Europe's five most populous nations was
up to 4.6 million in 2005, and this will double to up to
9.3 million by 2030 [1]. Over 100,000 Australians are cur-
rently living with Parkinson's disease [2] and in line with
estimates from Western Europe this number is also
expected to double by 2030 [1]. Since the most common
age of onset is 50–60 years and life expectancy is near nor-
mal, people with Parkinson's disease suffer the debilitat-
ing consequences of the disease over decades.
The mainstay of medical treatment for Parkinson's disease
is pharmacological therapy to boost depleted dopamine
levels. Despite optimal medication, people with Parkin-
son's disease living in the community experience frequent
and recurrent falls with devastating consequences. Up to
68% of people with Parkinson's disease will fall and up to
46% of people with Parkinson's disease will experience
recurrent falls each year [3-6]. These rates are around twice
of those in the general older population [6]. In addition,
a 12-month prospective study (n = 113) found that 27%
of people with Parkinson's disease fell at least once each
month and 15% fell at least once a week [3].
Among people with Parkinson disease, as many as 65% of
fallers will experience an injury secondary to their falls,
33% will suffer a fracture and 75% of falls will lead to use
of a health care service [7]. Falls and related fractures are
the most common secondary reason that people with Par-
kinson's disease are admitted to hospital [8]. These falls
have devastating consequences and are accompanied by
pain, reduced mobility and unacceptably high levels of
caregiver stress. Fear of falling is also greater in commu-
nity-dwelling people with Parkinson's disease than
healthy controls [9]. This results in restriction of activities,
compromising quality of life and predisposing to second-
ary reductions in muscle strength and cardiovascular fit-
ness.
Recently Latt (2006) tested a battery of physiological and
clinical variables considered to be potential risk factors for
falls in people with Parkinson's disease [3]. These
included Parkinson's specific impairments, such as slow-
ness of movement, poor balance, freezing of gait and cog-
nitive impairment as well as age-related impairments,
such as reduced lower limb muscle strength. After adjust-
ing for past falls, it was found that freezing of gait, poor
balance and lower limb muscle weakness were independ-
ent predictors of falls. Therefore, the logical targets for an
exercise program designed to reduce falls would be freez-
ing of gait, balance and lower limb muscle strength.
Systematic reviews in the general older population, have
found that exercise programs which specifically target bal-
ance and lower limb muscle strength are effective in pre-
venting falls [10,11]. In people with Parkinson's disease,
lower limb muscle strength and regular exercise are signif-
icantly correlated with physical abilities [12-15], therefore
highlighting the role of exercise as an appropriate inter-
vention in this population. Exercise has been shown to
improve balance [16-18] and strength [18,19] and cueing
training [20] has been shown to improve freezing of gait
[17] in people with Parkinson's disease. However, no pre-
vious randomised controlled trials have investigated an
exercise intervention aimed at reducing falls in people
with Parkinson's disease by simultaneously targeting all
three of these predictors of falls. The Weight-bearing Exer-
cise for Better Balance (WEBB) exercise program has been
developed to specifically target poor balance and lower
limb muscle weakness for people at risk of falls. The PD-
WEBB program used in this study includes progressive
weight-bearing balance and strength exercises along with
evidence-based cueing strategies to address freezing of
gait. (The PD-WEBB program is available from the authors
on request).
The primary aim of this randomised controlled trial is to
determine the effectiveness of the PD-WEBB exercise pro-
gram in reducing the rate of falls in people with Parkin-
son's disease. In addition, we will establish the cost
effectiveness of the program from the health provider's
perspective and determine the effects of the program on i)
risk factors for falls, ii) physical abilities, iii) fear of falling
and iv) quality of life.
Methods
Design
A prospective, randomised controlled trial will be con-
ducted with 230 community-dwelling participants with
Parkinson's disease (Figure 1).BMC Neurology 2009, 9:4 http://www.biomedcentral.com/1471-2377/9/4
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Participant selection
To be included in the study participants must meet the fol-
lowing inclusion criteria: (i) a diagnosis of idiopathic Par-
kinson's disease; (ii) aged 40 years or over; (iii) able to
walk independently with or without a walking frame; (iv)
fallen at least once in the past 12 months or found to be
at risk of falls on assessment; (v) have adapted to their cur-
rent anti-Parkinsonian medication for at least 2 weeks.
Participants will be excluded if they have a Mini-Mental
State Examination score of < 24, or suffer from unstable
cardiovascular disease, or suffer from other uncontrolled
Trial design Figure 1
Trial design.BMC Neurology 2009, 9:4 http://www.biomedcentral.com/1471-2377/9/4
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chronic conditions that would interfere with the safety
and conduct of the training and testing protocol or inter-
pretation of the results.
All volunteers will be screened by a physiotherapist. Med-
ical clearance will be required from each participant's
medical practitioner to certify him/her as able to partici-
pate in moderate-intensity semi-supervised exercise
before being accepted into the trial.
The study protocol has been approved by The University
of Sydney Human Research Ethics Committee (HREC
Number 11-2007/10487), and Sydney West Area Health
Service Human Research Ethics Committee (HREC2008/
9/4.13 (2865) AU RED 08/WMEAD/250) and written
informed consent will be obtained from all participants.
Measurements and Procedures
All participants will undergo two measurements: one on
entry to the study (pre-test) and one after the 6-month
intervention period (post-test). All pre-test measures will
be assessed prior to randomisation. Cognitive function
will be assessed with the Mini Mental State Examination
[21]. Measurements will be conducted one hour after each
participant's last dose of L-dopa, thus each participant will
be tested in their "on" phase.
Randomization
After completion of the pre-test assessment, participants
will be formally entered into the study and randomized to
intervention or control groups. Randomization will be
stratified by falls history (0–10 falls in the previous 12
months/more than 10 falls in the previous 12 months)
using a computer-generated random number schedule
with variable block sizes of 2–6. Randomization will be




The intervention group will undertake the PD-WEBB pro-
gram. This includes a 40–60 min program of progressive
balance and lower limb strengthening exercises 3 times a
week for 6 months as well as evidence-based cueing strat-
egies to reduce freezing of gait [20]. Participants will have
the option to participate in a support group-based program
in which they attend monthly exercise classes conducted
by a physiotherapist as well as perform the exercises at
home. If they choose this option, the exercises will be
updated by the physiotherapist at the class and they will
receive two to four home visits by the physiotherapist over
the 6 months to ensure that the exercises are performed
safely and effectively at home. Participants who choose
the home-based mode will have eight to ten sessions super-
vised and progressed by a physiotherapist over the 6
months. These participants will carry out the other ses-
sions independently, following specific written and picto-
rial instructions provided by the physiotherapist.
Exercises
All exercise sessions will include 5 minutes warm-up exer-
cises. The lower limb extensor muscle groups, which act to
prevent collapse of the lower limb (hip and knee exten-
sors and ankle plantarflexors) will be targeted with exer-
cises designed to enhance postural control (i. e. balance)
and muscle strength. The balance exercises include stand-
ing with a decreased base of support, forwards and side-
ways stepping/walking, and graded reaching activities in
standing. Strengthening exercises will include sit-to-stand,
forward or lateral step-ups onto a small block, semi squats
and heel raises in standing. Resistance for strengthening
exercises will be applied using weighted vests in a similar
protocol to one which has been successfully used by peo-
ple with multiple sclerosis in a home-based program [22].
Standard principles governing frequency, volume, dura-
tion, intensity and progression of exercise will be applied
[23]. Cueing strategies will be used to reduce freezing
[17,20,24]. These include identifying appropriate meth-
ods of cueing (cognitive, auditory, somatosensory) for
each participant and incorporating these cues into every-
day activities.
Safety
Participants will be instructed how to perform exercises
safely with stable supports (such as a table) located nearby
for additional support if required. Maintaining safety
while exercising will be a prime consideration when level
of difficulty of exercises is prescribed and progressed. Par-
ticipants will be provided with a booklet containing safety
precautions, instructions and photographs of exercises for
use in exercise sessions at home. In addition, they will be
provided with a logbook for recording exercises com-
pleted and effects of exercise (e.g. muscle soreness). Any
participant who does not demonstrate safety in the inde-
pendent performance of their exercises after two home
visits will be withdrawn from the study. Where appropri-
ate, family members and/or carers, will be encouraged to
assist with supervision and performance of the exercise
program.
The intervention group will also receive standardised falls
prevention advice in the form of a booklet.
Control group
The control group will receive their usual care from their
medical practitioner and community services. In addition,
standardised falls prevention advice in the form of a book-
let will be provided.BMC Neurology 2009, 9:4 http://www.biomedcentral.com/1471-2377/9/4
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Outcome measures
The primary outcome measure will be falls:
Falls will be assessed by comparing the number of falls in
intervention and control groups. The proportion of fallers
in each group will also be compared. Falls will be
recorded by the use of a "falls diary". All participants will
receive monthly calendars on entry to the study, with
instructions to record the following events: number of
falls, visits by or to nursing and allied health personnel,
general practitioner or specialists appointments and hos-
pitalisations. Participants will be asked to return the com-
pleted calendar monthly in pre-paid envelopes to the
research personnel who are unaware of group allocation.
All participants will also be telephoned monthly to record
any changes in medications, use of health resources and
verify any falls details (including how and where the fall
occurred, injuries suffered, medical intervention required
and limitations to activity as a result of a fall).
To evaluate the cost effectiveness of the exercise program
the following measures will be collected:
Costs of the intervention: the costs of implementing the
exercise program will be obtained from trial records and
research group financial records using actual costs when
available. Costs associated with developing and evaluat-
ing the exercise program will be excluded from the analy-
sis.
Costs of health services used for managing fall-related injuries:
use of public and private healthcare resources will be
recorded as part of the monthly telephone calls, over the
6-month intervention period.
The secondary outcome measures listed below will be col-
lected on entry to the study and at the end of the 6-month
intervention period by an assessor unaware of group allo-
cation. The order of measurements will be standardized.
Participants will be instructed not to inform the assessors
of their intervention status, and all home exercise equip-
ment will be removed or concealed prior to the post-
assessment.
Secondary outcome measures are:
(i) Parkinson's Disease Falls Risk Score: Falls risk status will
be determined using the Parkinson's disease-specific algo-
rithm developed in our recent large prospective cohort
study [3]. This involves weighted contributions from neu-
rological and physiological function measures including
gait freezing, impaired balance and lower limb weakness.
(ii) Maximal muscle strength of the knee extensor muscles
of each leg will be tested using a strain gauge [25].
(iii) Balance in standing, using the coordinated stability
test which requires participants to accurately adjust their
position in a steady and coordinated manner when their
centre of mass is near the limits of their base of support
[26].
(iv) Short Physical Performance Battery, including tests of
walking, balanced standing and sit to stand [27].
(v) Freezing of gait, using the Freezing of Gait Question-
naire [28].
(vi) Falls Efficacy Scale International, a falls efficacy ques-
tionnaire [29].
(vii) Health and Well-being, using the SF12v2™.
(viii) Habitual Physical Activity Questionnaire to quantify
the type and amount of regular physical activity.
(ix) PDQ-39, a Parkinson's disease specific quality of life
questionnaire [30].
(x) Positive and Negative Affect, using the Positive and Neg-
ative Affect Schedule (PANAS) [31].
Adverse events (defined as a significant injury or medical
event that causes the participant to seek attention from a
health professional or limit their activities) will be moni-
tored and recorded throughout the study during the
monthly telephone calls to each participant.
Statistical analysis
The number of falls per person-year will be analysed using
negative binomial regression to estimate the difference in
fall rates between the two groups, adjusted for previous
multiple faller status and other confounding variables if
required [32]. The proportion of fallers between groups
will be compared using the relative risk statistic. Between-
group comparisons of final test performance for the con-
tinuously-scored outcome measures will be made using
General Linear Models (ANCOVA) controlled for pre-test
performance. Baseline continuously-scored data will be
compared between groups using the student t-test. Ordi-
nally-scored data will be analysed for between group dif-
ferences using the non-parametric Mann Whitney U
statistic. An intention-to-treat approach will be used for
all analyses.
Economic analysis will be undertaken in the manner used
in previous falls prevention studies [33,34]. The total costs
in intervention and control groups (including the cost of
the exercise program, and costs of health and community
service contacts) and falls rates, will be used to calculate
an incremental cost per fall prevented in the interventionBMC Neurology 2009, 9:4 http://www.biomedcentral.com/1471-2377/9/4
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group compared with the control group. Bootstrapping
will be used to estimate a distribution around costs and
health outcomes and to calculate confidence intervals
around the cost-effectiveness ratio; one-way sensitivity
analyses will be conducted around key parameters.
Sample size
As fall rates will be compared between groups using inci-
dent rate ratios (IRR) from negative bionomial regression
models [32] we conducted an analysis of statistical power
using the nbpower command in the STATA software pack-
age. A total of 230 participants (115 per group) will be
required to provide 80% power to detect as significant, at
the 5% level, a 30% lower rate of falls for exercise subjects
than control subjects (i. e. IRR = 0.70). We assumed the
control group rate of falls would be 1 fall/person month
over the 6-month follow-up period, a conservative esti-
mate as the prospective cohort study [3] reported a falls
rate of 1.6 falls/person month in a 12-month follow up of
113 people with PD.
The sample size of 230 will also be sufficient to detect
between-group differences of 23% of control group values
in the coordinated stability (balance) measure (assuming
a control group mean of 18 and SD of 14) and 11% for
knee extension strength (assuming a control group value
of 16 kg and SD of 6). Both calculations are based on val-
ues found among fallers with PD [3] assuming 80%
power of a two-sided test at the 5% level, a correlation
between pre-and post measures of 0.7, and 15% dropouts.
Discussion
There is an urgent need to identify cost-effective evidence-
based interventions for reducing falls and related injuries
in people with Parkinson's disease. To date, no ade-
quately-powered studies have investigated exercise inter-
ventions aimed at reducing falls in people with
Parkinson's disease. Only three randomised controlled
trials have reported falls as outcomes. One study found a
38% (rate ratio = 0.62) reduction in rate of falling from a
fully-supervised 8-week program of treadmill walking but
was clearly under-powered (n = 18, 95% CI of RR 0.26 to
1.48, calculated by CS from published data) [35]. Another
reported improved balance, walking and confidence in
walking, and a non-significant 40% (odds ratio = 1.40)
increase in risk of falling following a 3-week home-based
program of rhythmical cueing of walking [17] (95% CI
0.63 to 3.1). The only study which targeted fallers [16]
investigated a 6-week home-based program of multi-
facetted exercise and showed promising results on balance
and a non-significant, but 26% reduced risk of falls (risk
ratio for repeat falls at 8 weeks = 0.74, 95% CI 0.47 to
1.15, calculated by CS from published data). A statistically
and clinically beneficial reduction in falls risk might have
become apparent if the interventions had been of longer
duration.
The PD-WEBB program has been designed for falls pre-
vention and so includes high challenge, yet safe, progres-
sive balance exercises targeting standing balance and
walking as well as progressive moderate to high intensity
leg strengthening exercises with resistance applied using
weighted vests. As different individuals have different
preferences for exercise, participants who are randomly
allocated to the exercise group will have the option to per-
form the 6-month program of exercises entirely at home
(home-based mode) or in association with their Parkin-
son's support group (support group-based mode) with an
additional home exercise program. Both modes of deliv-
ery incorporate semi-supervision by a physiotherapist and
are designed to be individually tailored. The randomized
controlled trial [17] which has addressed freezing (the
RESCUE trial) using cued walking practice found no over-
all effect on freezing, but a significant effect in a subgroup
of freezers. Therefore our exercise intervention will incor-
porate cueing strategies for overcoming freezing
[17,20,24] as well as balance and strength exercises.
We will investigate the effect of the PD-WEBB program in
people with Parkinson's disease using a randomized con-
trolled trial incorporating the features known to reduce
bias (i. e. concealed random allocation to groups, blinded
outcome assessment and intention to treat analysis) and
large enough to detect any effect of the intervention on fall
rates. This project will determine the effectiveness of the
exercise intervention in reducing falls, but will also deter-
mine the cost effectiveness of the intervention. This pro-
gram, if found to be effective, has the potential to be
implemented at a reasonable and sustainable cost within
existing community services. Any reduction in falls for
people with Parkinson's disease will reduce the personal
and financial costs to individuals with Parkinson's dis-
ease, their families, health care resources and the commu-
nity.
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